Bambuterol

Active ingredient description

Bambuterol is an active precursor of the selective β2-adrenergic agonist terbutaline. Bambuterol is the bis-N,N-dimethyl-carbamate of terbutaline. Bambuterol is a remarkably selective and potent inhibitor of cholinesterase. Bambuterol is indicated for the management of asthma, bronchospasm and/or reversible airways obstruction.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Bambuterol
R Respiratory system → R03 Drugs for obstructive airway diseases → R03C Adrenergics for systemic use → R03CC Selective beta-2-adrenoreceptor agonists
Discover more medicines within R03CC12

Medicines

Bambuterol is the active ingredient of these drugs:

Drug
Countries

Brazil

Austria Brazil Germany Singapore Spain

Hong Kong

Hong Kong

France

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

Y1850G1OVC - BAMBUTEROL

CAS registry number

81732-65-2 - bambuterol

SNOMED-CT

396462008 - Bambuterol (substance)